On Janurary 4, 2012 the FDA issued an update to their evaluation of Urogynecologic Surgical Mesh Implants or Transvaginal Mesh. This update states that the FDA is considering changing the classification of transvaginal mesh. This was based on assessments of the Medical Device Reports, also known as adverse event reports, and other literature. The consideration would look at changing the classification of transvaginal mesh from a Class II medical device to a Class III medical device.
For more information you can visit the FDA’s website on Urogynecologic Surgical Mesh Implants.
The attorneys at Kell Lampin, LLC continue to stay up to date on the results of any FDA studies. Our experienced attorneys are always available to answer any questions you may have regarding the current lawsuits being filed against the manufacturers of transvaginal mesh medical devices. Contact us today at 1-866-804-4357 for a free case evaluation.